Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aurelius Omlin

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
European Urology|May 8, 2018
Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate CancerJun Gong, Aurelius Omlin, Sumanta K Pal, et al.
Journal of Pain and Symptom Management|November 20, 2012
Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysisRolf Oberholzer, Jane B Hopkinson, Kim Baumann, et al.
Clinical Genitourinary Cancer|March 4, 2015
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and CabazitaxelAurelius Omlin, Oliver Sartor, Christian Rothermundt, et al.
Cardiovascular and Interventional Radiology|February 28, 2024
Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot StudyOrlando Burkhardt, Dominik Abt, Lukas Hechelhammer, et al.
Frontiers in Oncology|February 25, 2025
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settingsArmen Aprikian, Amit Bahl, Aurelius Omlin, et al.
Critical Reviews in Oncology/Hematology|January 11, 2011
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancerDavid Blum, Aurelius Omlin, Vickie E Baracos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2014
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancerDavid Lorente, Diletta Bianchini, Alejo Rodriguez-Vida, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2026
Could we reduce renal toxicity of [<sup>177</sup>Lu]Lu-PSMA radioligand therapy with furosemide?Sabin G Pop, Klaus Strobel, Jakob Heimer, et al.
Oncology Research and Treatment|June 7, 2019
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic ModelPatrick Betschart, Christa Babst, Sabine Schmid, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2024
Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland - A claims data analysisMichael Stucki, Stephanie Dosch, Markus Gnädinger, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
European Urology|May 8, 2018
Influence of an International Consensus Conference on Practice Patterns in Advanced Prostate CancerJun Gong, Aurelius Omlin, Sumanta K Pal, et al.
Journal of Pain and Symptom Management|November 20, 2012
Psychosocial effects of cancer cachexia: a systematic literature search and qualitative analysisRolf Oberholzer, Jane B Hopkinson, Kim Baumann, et al.
Clinical Genitourinary Cancer|March 4, 2015
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and CabazitaxelAurelius Omlin, Oliver Sartor, Christian Rothermundt, et al.
Cardiovascular and Interventional Radiology|February 28, 2024
Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot StudyOrlando Burkhardt, Dominik Abt, Lukas Hechelhammer, et al.
Frontiers in Oncology|February 25, 2025
Meta-analysis to evaluate the comparative effectiveness of enzalutamide and abiraterone acetate for first-line treatment of metastatic castration-resistant prostate cancer in real-world settingsArmen Aprikian, Amit Bahl, Aurelius Omlin, et al.
Critical Reviews in Oncology/Hematology|January 11, 2011
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancerDavid Blum, Aurelius Omlin, Vickie E Baracos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2014
Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancerDavid Lorente, Diletta Bianchini, Alejo Rodriguez-Vida, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2026
Could we reduce renal toxicity of [<sup>177</sup>Lu]Lu-PSMA radioligand therapy with furosemide?Sabin G Pop, Klaus Strobel, Jakob Heimer, et al.
Oncology Research and Treatment|June 7, 2019
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic ModelPatrick Betschart, Christa Babst, Sabine Schmid, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2024
Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland - A claims data analysisMichael Stucki, Stephanie Dosch, Markus Gnädinger, et al.
Pageof 10